iStent inject^® in the Refractive Cataract Practice

Robert J. Cionni, MD

Increasing Your Firepower with iStent inject^®

Arsham Sheybani, MD

Eliminating MIGS Barriers with iStent inject^®

John P. Berdahl, MD

Exceptional Outcomes with the iStent inject^®

Thomas W. Samuelson, MD

iStent inject^® - The Next Generation of Microinvasive Glaucoma Surgery

Iqbal Ike K. Ahmed, MD, FRCSC

Visual Outcomes With the iStent

Arsham Sheybani, MD

When to Use MIGS: The Refractive Cataract Specialist Perspective

Kerry Solomon, MD

The Learning Curve

Elizabeth Yeu, MD

When to Use MIGS: The Glaucoma Specialist Perspective

Mark Gallardo, MD

Surgical Outcomes of the iStent

Tal Raviv, MD

Offering Patients a Premium Experience

Nathan Radcliffe, MD

MIGS and Your Practice

Arsham Sheybani, MD

Safety of the iStent

Arsham Sheybani, MD

Working With a Referral Base

Arsham Sheybani, MD

iStent Learning Curve

Tal Raviv, MD

Addressing Glaucoma at the Time of Cataract Surgery

Nathan Radcliffe, MD

The iStent Procedure

Arsham Sheybani, MD

What To Expect When Adopting the iStent

Nathan Radcliffe, MD

MIGS Technology and the Future

Tal Raviv, MD

Safety of the iStent

Tal Raviv, MD

Making the MIGS Algorithm Work

Ike Ahmed, MD

Adding MIGS to Your Armamentarium

Elizabeth Yeu, MD

The iStent Journey

Kerry Solomon, MD

Surgical Outcomes

Elizabeth Yeu, MD

Techniques for Implanting the iStent

Elizabeth Yeu, MD

Disruptive Technology That Won't Disrupt Your Practice

Cathleen McCabe, MD

MIGS Economics 101

Matt Jensen

Cases That Catch Your Eye

Steven Sarkisian, MD

Raising the Outcomes Bar

Robert Cionni, MD

The iStent Premium Package

Jeffrey Whitman, MD

Efficacy With the iStent

I. Paul Singh, MD

Increased Surgical Efficiency With the iStent

David Goldman, MD

Pearls for Using the iStent in Cataract Surgery

Mitchell Shultz, MD

The Evolution of MIGS and the iStent Journey

Richard Lindstrom, MD

Refining iStent Microsurgery: Making a Case for Safer Glaucoma Intervention

Thomas Samuelson, MD

Why I Adopted iStent as a Refractive Cataract & Corneal Surgeon

Edward Holland, MD

Making It Work for You: Optimizing iStent in Your Practice

John Berdahl, MD

What's Next: The Future of Titratable Therapy

Ike Ahmed, MD

Why iStent

David Goldman MD, Thomas Samuelson, MD

Surgical Pearls

David Goldman MD, Thomas Samuelson, MD

Data Review

David Goldman MD, Thomas Samuelson, MD

Practice Success

David Goldman MD, Thomas Samuelson, MD

MIGS: Glaukos iStent User Group: Surgical Approach to MIGS

Ike K. Ahmed MD, L. Jay Katz MD, Richard A. Lewis MD, Thomas W. Samuelson MD

Surgical Approach to MIGS: Part 6

Surgical Approach to MIGS: Part 5

Surgical Approach to MIGS: Part 4

Surgical Approach to MIGS: Part 3

Surgical Approach to MIGS: Part 2

Surgical Approach to MIGS: Part 1

MIGS: Glaukos iStent User Group - A True Team Effort, Part 5

MIGS: Glaukos iStent User Group - A True Team Effort, Part 4

MIGS: Glaukos iStent User Group - A True Team Effort, Part 3

MIGS: Glaukos iStent User Group - A True Team Effort, Part 2

MIGS: Glaukos iStent User Group - A True Team Effort, Part 1

MIGS: Glaukos iStent User Group: Case Studies - Part 7

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 6

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 5

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 4

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 3

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 2

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 1

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 6

Steven D. Vold, MD

MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 5

Steven D. Vold, MD

MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 4

Robert Cionni MD

MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 3

Robert Cionni MD

MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 2

Richard A. Lewis MD

MIGS: Glaukos iStent User Group: Clinical Outcomes and Evidence - Part 1

Richard A. Lewis MD

Glaukos Symposia Part 13.

Glaukos Symposia Part 12

Glaukos Symposia Part 11

Glaukos Symposia Part 10

Glaukos Symposia Part 9

Glaukos Symposia Part 8

Glaukos Symposia Part 7

Glaukos Symposia Part 6

Glaukos Symposia Part 5

Glaukos Symposia Part 4

Glaukos Symposia Part 3

Glaukos Symposia Part 2

Glaukos Symposia Part 1

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 5

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 4

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 3

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 2

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 1

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS